Documented spirometry within the last 12 months with a post-bronchodilator FEV1 \< 80% of predicted and an FEV1 \< 70% of FVC (4 puffs of salbutamol 30 minutes prior to spirometry)
Patients being hospitalized for an exacerbation at the University Hospitals of Leuven at time of enrollment
Patients currently treated with Spiriva for at least 4 weeks at the start of the data collection (i.e. 4 weeks after hospitalization for an exacerbation)
Oral fluency in Dutch
Being capable to provide informed consent
You may not be if
A documented history of asthma or another respiratory disease
An expected life expectancy of \< 6 months
Cognitive impairment (Mini Mental State Examination test results \< 25) or presence of other co-morbidities preventing patients from completing the self-report instruments and/or using electronic monitoring
Institutionalized patients, patients living in a nursing home or patients not managing their medications independently
Clareo Health | Adherence to Medication and Its Impact on Chronic Obstructive Pulmonary Disease (COPD) Exacerbations: The AMICE Prospective Study
